US$ 23.75
igf-1 lr3 site specific injection - 1mg Recombinant Human LR3 IGF-I/IGF-1 GMP
Description
doi: 10.1111/j.1399-6576.1996.tb04493.x

Guertin, D

Med Hypotheses 149: 110543

Storage period after opening: corresponds to the actual storage period

Moreover, high-dose IVC is powerful as an adjuvant treatment for cancer, acting synergistically with many standard (chemo-) therapies, as well as a method for mitigating the toxic side-effects of chemotherapy
